Corrigendum to “Glutathione S-transferases P1-mediated interleukin-6 in tumor-associated macrophages augments drug-resistance in MCF-7 breast cancer” [Biochem. Pharmacol. 182 (2020) 114289]
Xiaoliang Dong(Jiangnan University), Li‐Long Pan(Jiangnan University), Sheng-Zhou Yu(Jiangnan University), Zhen Guo(Nanjing University), Jing Wang(Qilu Hospital of Shandong University), Xiaohua Pan(Qingdao University), Jiaqi Cui(China Pharmaceutical University), Jia Sun(Huazhong Agricultural University), Jun Yang(Jiangnan University), Rongmei Sun(China Pharmaceutical University)
Cited by 1
Related Papers
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
|Nature Medicine|2015|355
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
|Clinical Journal of the American Society of Nephrology|2016|192
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
|PLoS ONE|2018|161